Boston Approves Big Meds and Eds Projects
A $1.7-billion cancer hospital and Boston University’s newest academic tower received approval from Boston Planning & Development Agency directors at their June meeting.
A $1.7-billion cancer hospital and Boston University’s newest academic tower received approval from Boston Planning & Development Agency directors at their June meeting.
There’s a new line item with a big question mark for developers drawing up project expenses trade wars ramp up. And it could weaken Greater Boston’s traditional defenses against downturns: the “eds-and-meds” sector.
Dana-Farber Cancer Institute will expand its lab and research space in Boston’s Longwood Medical Area and the Fenway while its office space shrinks under a permanent remote and hybrid workforce model.
Construction of New England’s first dedicated cancer hospital would span a seven-year period and create 320 inpatient beds at a new 14-story tower in Boston’s Longwood Medical Area.
A joint venture of Celera Properties and AEW has acquired a Methuen medical office building that was recently converted from vacant office space by Boston-based Marcus Partners.
A $25 million redevelopment in Methuen has created a 94,000-square-foot medical office facility that will be anchored by Dana-Farber Cancer Institute.
Dana-Farber Cancer Institute will anchor a medical office building conversion project planned by Boston-based developer Marcus Partners in Methuen.
Dana-Farber Cancer Institute has acquired an office condominium in the Longwood Center research building in Boston for $239 million from the original development team.